Truist Downgrades GitLab Amid Rising Competitive and Execution Risks
Truist cuts GitLab rating to Hold and lowers its price target, citing low visibility, execution risks, and competitive pressure from GitHub’s lower-priced enterprise tier.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Truist cuts GitLab rating to Hold and lowers its price target, citing low visibility, execution risks, and competitive pressure from GitHub’s lower-priced enterprise tier.
Mizuho double downgraded Canadian Solar to Underperform, citing an overdone rally and uncertainty around U.S. factory and compliance issues.
Target trimmed its 2025 profit outlook due to cautious shoppers and soft demand. Incoming CEO Michael Fiddelke plans a $5 billion investment next year to fuel growth.
Lowe's (LOW) Q3 2025 earnings show 0.4% comparable sales growth driven by 11% online gains. Company raises full-year sales outlook to $86B despite market headwinds.
Citizens JMP initiated coverage on Nebius, Iren, Riot Platforms, and Cipher Mining with Outperform ratings, citing critically scarce power supply for high-performance computing and AI as a major growth driver.
Goldman Sachs upgrades MP Materials to Buy with a $77 target, while Canaccord raises Lithium Americas to Hold. Analysts cite stronger market outlooks and strategic advantages.